Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 6Sanofi
02 2Dr. Reddy's Laboratories
03 2Actavis Inc
04 2Central Procurement & Supplies Unit
05 2Cheplapharm Arzneimittel Gmbh
06 2IVAX Pharmaceuticals Inc
07 2Interpharm
08 1Nesher Pharmaceuticals USA LLC
09 2ORIFARM GROUP AS
10 1Orspec Pharma
11 3Paranova Pharmaceuticals Ab
12 4Pfizer Inc
13 1Pharma Regulatory Services Limited
14 1Pharmaco
15 2Rising Pharmaceuticals Inc
16 2SUPERPHARM
17 2Sun Pharmaceutical Industries Limited
18 2Teva Pharmaceutical Industries
19 3Viatris
01 1CAP
02 1CAPSULE
03 3CAPSULE, EXTENDED RELEASE;ORAL
04 20CAPSULE;ORAL
05 2Capsule
06 1Depot tablet
07 1Disopyramide 100Mg 40 Combined Oral Use
08 1Disopyramide 250Mg 20 Joined' Oral Use
09 4Hard Capsule
10 6Tablet
11 1capsule
12 1Blank
01 3Authorised
02 1Authorized
03 15DISCN
04 7Deregistered
05 1Generic
06 1Prescription
07 8RX
08 1Withdrawn
09 5Blank
01 19DISOPYRAMIDE PHOSPHATE
02 2Dicorynan
03 1Disopyramide Phosphate
04 1Durbis
05 7Durbis Retard
06 2NORPACE
07 2NORPACE CR
08 1RYTHMODAN
09 2Ritmodan
10 1Ritmodan Retard
11 2Rythmodan
12 1Rythmodan (Canada)
13 1Rythmodan 100 mg Capsules
01 2Australia
02 1Canada
03 2Italy
04 4Malta
05 1Norway
06 1South Africa
07 1Spain
08 7Sweden
09 23USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Ritmodan
Dosage Form : Disopyramide 100Mg 40 Combined Oral Use
Dosage Strength : 40 cps 100 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DISOPYRAMIDE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1985-05-31
Application Number : 70173
Regulatory Info : RX
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Ritmodan Retard
Dosage Form : Disopyramide 250Mg 20 Joined' Oral Use
Dosage Strength : 20 CPR 250 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Norway
Brand Name : Durbis Retard
Dosage Form : Depot tablet
Dosage Strength : 250 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Durbis
Dosage Form : Capsule
Dosage Strength : 100mg
Packaging :
Approval Date : 12/05/1978
Application Number : 19780512000016
Regulatory Info : Deregistered
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Durbis Retard
Dosage Form : Tablet
Dosage Strength : 250mg
Packaging :
Approval Date : 16/10/1981
Application Number : 19811016000032
Regulatory Info : Deregistered
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Rythmodan 100 mg Capsules
Dosage Form : CAP
Dosage Strength : 100mg
Packaging : 100X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DISOPYRAMIDE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 1985-05-31
Application Number : 70173
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DISOPYRAMIDE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1986-02-02
Application Number : 70240
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DISOPYRAMIDE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 1986-02-02
Application Number : 70241
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DISOPYRAMIDE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1985-11-18
Application Number : 70186
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DISOPYRAMIDE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 1985-11-18
Application Number : 70187
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NORPACE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-01-01
Application Number : 17447
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NORPACE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 1982-01-01
Application Number : 17447
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NORPACE CR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-07-20
Application Number : 18655
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NORPACE CR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 1982-07-20
Application Number : 18655
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DISOPYRAMIDE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1985-02-22
Application Number : 70101
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DISOPYRAMIDE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 1985-02-22
Application Number : 70102
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DISOPYRAMIDE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1985-06-14
Application Number : 70138
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DISOPYRAMIDE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 1985-06-14
Application Number : 70139
Regulatory Info : DISCN
Registration Country : USA
Contact Us!
